WallStreetZenWallStreetZen

NASDAQ: IOSP
Innospec Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their IOSP stock forecasts and price targets.

Forecast return on equity

Is IOSP forecast to generate an efficient return?

Company
12.32%
Industry
32.57%
Market
144.34%
IOSP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is IOSP forecast to generate an efficient return on assets?

Company
9.11%
Industry
9.88%
IOSP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IOSP earnings per share forecast

What is IOSP's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$5.03-11.41%
Avg 2 year Forecast
$6.12+7.81%
Avg 3 year Forecast
$6.86+20.86%
IOSP's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

IOSP revenue forecast

What is IOSP's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$2.0B+4.23%
Avg 2 year Forecast
$2.1B+10.15%
Avg 3 year Forecast
$2.1B+13.62%
IOSP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IOSP earnings growth forecast

How is IOSP forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
2.94%
Industry
21.15%
Market
70.08%
IOSP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
IOSP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
IOSP's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

IOSP revenue growth forecast

How is IOSP forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
4.6%
Industry
12.63%
Market
12.94%
IOSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IOSP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IOSP vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
IOSP$79.11N/AN/A
MTX$61.64$90.00+46.01%Strong Buy
CC$13.35$16.86+26.27%Buy
OLN$17.66$20.69+17.17%Hold
NGVT$61.97N/AN/A
View Top Specialty Chemical Stocks

Innospec Stock Forecast FAQ

What is IOSP's earnings growth forecast for 2026-2028?

(NASDAQ: IOSP) Innospec's forecast annual earnings growth rate of 2.94% is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 21.15%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 70.08%.

Innospec's earnings in 2026 is $140,400,000.On average, 5 Wall Street analysts forecast IOSP's earnings for 2026 to be $123,946,186, with the lowest IOSP earnings forecast at $114,660,075, and the highest IOSP earnings forecast at $130,609,032. On average, 5 Wall Street analysts forecast IOSP's earnings for 2027 to be $150,829,109, with the lowest IOSP earnings forecast at $143,868,220, and the highest IOSP earnings forecast at $156,472,207.

In 2028, IOSP is forecast to generate $169,086,047 in earnings, with the lowest earnings forecast at $162,455,222 and the highest earnings forecast at $174,059,166.

If you're new to stock investing, here's how to buy Innospec stock.

What is IOSP's revenue growth forecast for 2026-2028?

(NASDAQ: IOSP) Innospec's forecast annual revenue growth rate of 4.6% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 12.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.94%.

Innospec's revenue in 2026 is $1,873,800,000.On average, 5 Wall Street analysts forecast IOSP's revenue for 2026 to be $48,105,505,035, with the lowest IOSP revenue forecast at $45,888,661,485, and the highest IOSP revenue forecast at $49,854,348,280. On average, 5 Wall Street analysts forecast IOSP's revenue for 2027 to be $50,839,612,080, with the lowest IOSP revenue forecast at $48,277,926,200, and the highest IOSP revenue forecast at $53,130,350,415.

In 2028, IOSP is forecast to generate $52,440,665,755 in revenue, with the lowest revenue forecast at $50,396,243,370 and the highest revenue forecast at $53,992,456,240.

What is IOSP's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: IOSP) forecast ROA is 9.11%, which is lower than the forecast US Specialty Chemicals industry average of 9.88%.

What is IOSP's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: IOSP) Innospec's current Earnings Per Share (EPS) is $5.68. On average, analysts forecast that IOSP's EPS will be $5.03 for 2026, with the lowest EPS forecast at $4.66, and the highest EPS forecast at $5.30. On average, analysts forecast that IOSP's EPS will be $6.12 for 2027, with the lowest EPS forecast at $5.84, and the highest EPS forecast at $6.35. In 2028, IOSP's EPS is forecast to hit $6.86 (min: $6.60, max: $7.07).

What is IOSP's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: IOSP) forecast ROE is 12.32%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.